Laurence Meyer Selected Research

HIV Seropositivity

10/2014	Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study.
3/2013	Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply.
9/2012	Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.
1/2012	Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.
10/2011	Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines.
9/2008	Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.
9/2007	The HIV RNA setpoint theory revisited.
7/2005	Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.
5/2005	Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?
10/2002	Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurence Meyer Research Topics

Disease

70	Infections 11/2022 - 10/2002
43	HIV Infections (HIV Infection) 01/2022 - 03/2003
34	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 04/2002
18	Disease Progression 01/2021 - 04/2002
14	Pain (Aches) 10/2019 - 01/2006
10	HIV Seropositivity 10/2014 - 10/2002
9	Inflammation (Inflammations) 11/2021 - 01/2012
8	Viremia 01/2022 - 03/2003
7	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022 - 01/2013
7	Neuralgia (Stump Neuralgia) 06/2020 - 01/2006
6	Neoplasms (Cancer) 01/2021 - 03/2005
5	Hyperalgesia 06/2020 - 01/2010
4	Persistent Infection 01/2021 - 09/2005
4	Painful Neuropathy 06/2020 - 09/2010
4	Chronic Pain 05/2019 - 12/2009
3	Insulin Resistance 01/2015 - 01/2012
2	Demyelinating Diseases (Demyelinating Disease) 03/2022 - 11/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 05/2008
2	Breast Neoplasms (Breast Cancer) 06/2020 - 11/2015
2	Sepsis (Septicemia) 01/2020 - 01/2018
2	AIDS Dementia Complex 01/2018 - 07/2014
2	Hepatitis 01/2018 - 04/2013
2	Coinfection 09/2015 - 04/2013
2	Liver Diseases (Liver Disease) 06/2014 - 04/2013
2	Necrosis 02/2014 - 01/2012
2	Peripheral Nerve Injuries 09/2010 - 09/2010
1	Chronic Progressive Multiple Sclerosis 03/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2022
1	Weight Gain 11/2021
1	Obesity 11/2021
1	Overweight 11/2021

Drug/Important Bio-Agent (IBA)

25	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2004
16	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2005
14	Pharmaceutical PreparationsIBA 01/2021 - 12/2003
8	AntibodiesIBA 11/2021 - 09/2005
7	EnzymesIBA 01/2021 - 08/2009
7	NeurosteroidsIBA 10/2019 - 12/2009
6	Tenofovir (Viread)FDA Link 01/2022 - 01/2018
5	Lipopolysaccharide ReceptorsIBA 11/2021 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
5	SteroidsIBA 10/2019 - 01/2006
4	Darunavir (Prezista)FDA Link 01/2022 - 01/2018
4	C-Reactive ProteinIBA 11/2021 - 12/2007
4	Emtricitabine (Emtriva)FDA Link 10/2021 - 01/2018
4	Peptides (Polypeptides)IBA 01/2021 - 09/2005
4	Chemokine ReceptorsIBA 01/2021 - 02/2003
4	AntigensIBA 01/2021 - 05/2007
4	Pregnanolone (Allopregnanolone)IBA 06/2020 - 09/2010
4	Biological ProductsIBA 01/2018 - 12/2006
4	efavirenz (Sustiva)FDA Link 01/2018 - 08/2012
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2009
3	RacivirIBA 01/2022 - 12/2015
3	Complement System Proteins (Complement)IBA 01/2021 - 04/2012
3	VaccinesIBA 12/2020 - 01/2014
3	Glycoproteins (Glycoprotein)IBA 10/2020 - 10/2018
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 04/2015
2	LigandsIBA 03/2022 - 03/2013
2	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2014
2	dolutegravirIBA 01/2022 - 01/2022
2	IntegrasesIBA 01/2022 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2015
2	Insulin (Novolin)FDA Link 11/2021 - 01/2012
2	Doxycycline (Periostat)FDA LinkGeneric 10/2021 - 01/2018
2	Viral RNAIBA 01/2021 - 08/2015
2	AcetoneIBA 06/2020 - 12/2018
2	Meropenem (Merrem)FDA LinkGeneric 01/2020 - 01/2018
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2020 - 01/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2019 - 12/2009
2	gamma-Aminobutyric Acid (GABA)IBA 10/2019 - 12/2009
2	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2014
2	HLA-B Antigens (HLA-B)IBA 01/2019 - 07/2013
2	Neutralizing AntibodiesIBA 01/2019 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2018 - 01/2013
2	Lopinavir FDA Link 01/2018 - 04/2015
2	Interleukin-10 (Interleukin 10)IBA 02/2014 - 01/2012
2	InterleukinsIBA 02/2014 - 12/2006
2	HLA-B57 antigenIBA 01/2014 - 07/2013
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2013 - 12/2006
2	CytokinesIBA 09/2012 - 12/2009
2	Reverse Transcriptase InhibitorsIBA 08/2012 - 03/2009
2	NucleosidesIBA 08/2012 - 03/2009
2	Substance PIBA 09/2010 - 12/2009
2	Calcitonin Gene-Related PeptideIBA 09/2010 - 12/2009
2	Dehydroepiandrosterone (DHEA)IBA 01/2010 - 01/2008
1	Myelin-Oligodendrocyte GlycoproteinIBA 03/2022
1	Myelin Basic ProteinIBA 03/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 01/2022
1	hepatitis B hyperimmune globulinIBA 01/2022
1	CobicistatIBA 01/2022
1	T Cell Transcription Factor 1IBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2021

Therapy/Procedure

45	Therapeutics 11/2022 - 10/2002
20	Highly Active Antiretroviral Therapy (HAART) 11/2021 - 03/2003
9	Art Therapy 01/2021 - 05/2005
6	Drug Therapy (Chemotherapy) 06/2020 - 09/2010
3	Condoms (Condom) 01/2018 - 12/2015
2	Duration of Therapy 03/2015 - 01/2013
2	First Aid (Aids, First) 09/2008 - 10/2002